Ljungberg T
J Pharm Pharmacol. 1986 Jul;38(7):520-5. doi: 10.1111/j.2042-7158.1986.tb04627.x.
The locomotion and stereotyped behaviours induced by the two dopamine agonists, 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in rats have been investigated using a holeboard apparatus. Unlike apomorphine, D 145 did not induce compulsive gnawing, but it did induce locomotion dose-dependently. However, the pattern of locomotion was different from that induced by apomorphine and the locomotion itself was potently antagonized by haloperidol but not by sulpiride; this is the opposite to apomorphine-induced locomotion. This indicates that locomotion induced by dopamine agonists is not a unitary phenomenon but that different 'types' of locomotion, with different pharmacological properties, can be induced. Low doses of D 145, given before apomorphine, reduced apomorphine-induced gnawing and enhanced apomorphine-induced locomotion. The long lasting 'priming' effect known to occur after repetitive injections of apomorphine was not mimicked by D 145. Apomorphine and D 145 are considered to be two specific DA agonists; their behavioural-pharmacological profiles, however, are quite different.
使用洞板装置研究了两种多巴胺激动剂1-氨基-3,5-二甲基金刚烷(D 145)和阿扑吗啡在大鼠中诱导的运动和刻板行为。与阿扑吗啡不同,D 145不会诱导强迫性啃咬,但它确实会剂量依赖性地诱导运动。然而,运动模式与阿扑吗啡诱导的不同,并且运动本身被氟哌啶醇强烈拮抗,而不被舒必利拮抗;这与阿扑吗啡诱导的运动相反。这表明多巴胺激动剂诱导的运动不是单一现象,而是可以诱导出具有不同药理学特性的不同“类型”的运动。在阿扑吗啡之前给予低剂量的D 145,可减少阿扑吗啡诱导的啃咬并增强阿扑吗啡诱导的运动。D 145不会模拟重复注射阿扑吗啡后已知会出现的持久“启动”效应。阿扑吗啡和D 145被认为是两种特异性多巴胺激动剂;然而,它们的行为药理学特征却大不相同。